Molecular mechanism of androgen action

Trends in Endocrinology and Metabolism

Volumn 9, Issue 8, 1998, Pages 317-324

  Hiipakka, Richard A ^a   Liao, Shutsung ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; CELL NUCLEUS RECEPTOR; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TRANSCRIPTION FACTOR;

ANDROGEN METABOLISM; CANCER INHIBITION; CHILDBIRTH; FETUS DEVELOPMENT; GENE MUTATION; GENETIC TRANSCRIPTION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSIVE ELEMENT; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DOMAIN; PROTEIN FAMILY; RECEPTOR GENE; REVIEW; SEXUAL MATURATION;

EID: 0031709047     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00081-2     Document Type: Review

References (63)

1. Anderson KM, Liao S Selective retention of dihydrotestosterone by prostatic nuclei. Nature. 219:1968;277-279.
2. Berthold AA Transplantation der Hoden. Arch Anat Physiol Wiss Med. 16:1849;42-46.
3. Brown CJ, Goss SJ, Lubahn DBet al. Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet. 44:1989;264-269.
4. Bruchovsky N, Wilson JD The conversion of testosterone to 5α-androstan-17β-ol-3-one by rat prostate in vivo and in vitro. J Biol Chem. 243:1968;2012-2021.
5. Brzozowski AM, Pike ACW, Dauter Zet al. Molecular basis of agonism and antagonism in the estrogen receptor. Nature. 389:1997;753-758.
6. Bull HG, Garcia-Calvo M, Andersson Set al. Mechanism-based inhibition of human steroid 5α-reductase by Finasteride: enzyme-catalyzed formation of NADP-dihydrofinasteride, a potent bisubstrate analog inhibitor. J Am Chem Soc. 118:1996;2359-2365.
7. Chamberlain NL, Driver ED, Miesfeld RL The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22:1994;3181-3186.
8. Chang C, Kokontis J, Liao S Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci U S A. 85:1988;7211-7215.
9. Choong CS, Kemppainen JA, Zhou Z, Wilson EM Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol. 10:1996;1527-1535.
10. Clever U, Karlson P Induktion von Puff-veränderungen in den Speicheldrüsenchromosomen von Chironomus Tentans durch Ecdyson. Exp Cell Res. 20:1960;623-626.
11. Coetzee GA, Ross RK Prostate cancer and the androgen receptor. J Natl Cancer Inst. 86:1994;872-873.
12. Culig Z, Hobisch A, Cronauer MVet al. Androgen receptor activation in prostate tumor cell lines by insulin-like growth factor-1, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54:1994;5474-5478.
13. Ding VDH, Moller DE, Feeney WPet al. Sex hormone-binding globulin mediates prostate androgen receptor action via a novel signaling pathway. Endocrinology. 139:1998;213-218.
14. Evans BAJ, Griffiths K, Morton MS Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol. 147:1995;295-302.
15. Fischer L, Catz D, Kelley D An androgen receptor mRNA isoform associated with hormone-induced cell proliferation. Proc Natl Acad Sci U S A. 90:1993;8254-8258.
16. Froesch BA, Takayama S, Reed JC BAG-1L protein enhances androgen receptor function. J Biol Chem. 273:1998;11660-11666.
17. Gardner FH, Besa EC Physiologic mechanisms and the hematopoietic effects of the androstanes and their derivatives. Curr Top Hematol. 4:1983;123-195.
18. Giovannucci E, Stampfer MJ, Krithivas Ket al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A. 94:1997;3320-3323.
19. Gottlieb B, Trifiro M, Lumbroso R, Pinsky L The androgen receptor gene mutation database. Nucleic Acids Res. 25:1997;158-162.
20. Green H Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism. Cell. 74:1993;955-956.
21. Hollenberg SM, Weinberger C, Ong ESet al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 318:1985;635-641.
22. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci U S A. 93:1996;4948-4952.
23. Hiipakka RA, Liao S: 1995. Androgen physiology: androgen receptors and action. In DeGroot LI, ed. Endocrinology. Philadelphia, W.B. Saunders, pp 2336-2351.
24. Huggins C, Steven RE, Hodges CV Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg. 43:1941;209-223.
25. Ikonen T, Palvimo JJ, Kallio PK, Reinikainen P, Jänne O Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology. 135:1994;1359-1366.
26. Ikonen T, Palvimo JJ, Jänne OA Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem. 272:1997;29821-29828.
27. Jensen EV, Jacobson HI Basic guides to the mechanism of estrogen action. Recent Prog Horm Res. 18:1962;387-414.
28. Jenster G, van der Korpu HAGM, van Vroonhoven C, van der Kwast T, Trapman J, Brinkman AO Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol. 5:1991;1396-1404.
29. Joly-Pharaboz MO, Soave MC, Nicolas Bet al. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP. J Steroid Biochem Mol Biol. 55:1995;67-76.
30. Kokontis JM, Liao S Molecular action of androgen in normal and neoplastic prostate. Vitam Horm. 55:1999;219-307.
31. Kokontis J, Ito K, Hiipakka RA, Liao S Expression and function of normal and LNCaP androgen receptors in androgen-insensitive human prostatic cancer cells: altered hormone and antihormone specificity in gene transactivation. Receptor. 1:1991;271-279.
32. Kokontis J, Takakura K, Hay N, Liao S Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res. 54:1994;1566-1573.
33. Kip1 in androgen-induced cell cycle arrest. Mol Endocrinol. 12:1998;941-953.
34. LaSpada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 352:1991;77-79.
35. Lavinsky RM, Jepsen K, Heinzel Tet al. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci U S A. 95:1998;2920-2925.
36. Liao S Influence of testosterone on template activity of prostatic activity of prostatic ribonucleic acids. J Biol Chem. 240:1965;1236-1243.
37. Liao S, Fang S Receptor-proteins for androgens and the mode of action of androgens on gene transcription in ventral prostate. Vitam Horm. 27:1969;17-90.
38. Liao S, Hiipakka RA Selective inhibition of steroid 5α-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem Biophys Res Commun. 214:1995;833-838.
39. Liao S, Williams-Ashmann HG An effect of testosterone on amino acid incorporation by prostatic ribonucleoprotein particles. Proc Natl Acad Sci U S A. 48:1962;1956-1964.
40. Liao S, Leininger KR, Sagher D, Barton RW Rapid effect of testosterone on ribonucleic acid polymerase activity of rat ventral prostate. Endocrinology. 77:1965;763-765.
41. Liang T, Liao S Inhibition of steroid 5α-reductase by specific aliphatic unsaturated fatty acids. Biochem. J 285:1992;557-562.
42. Liang T, Liao S Growth suppression of hamster flank organs by topical application of g-linolenic and other fatty acid inhibitors of 5α-reductase. J Invest Dermatol. 109:1997;152-157.
43. Lubahn DB, Joseph DR, Sar Met al. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in the prostate. Mol Endocrinol. 2:1988;1265-1275.
44. Mahendroo MS, Cala KM, Russell DW 5α-Reduced androgens play a key role in murine parturition. Mol Endocrinol. 10:1996;380-392.
45. Mahendroo MS, Cala KM, Landrum CP, Russell DW Fetal death in mice lacking 5α-reductase type 1 caused by estrogen excess. Mol Endocrinol. 11:1997;917-927.
46. McEwan IJ, Gustafsson J Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. Proc Natl Acad Sci USA. 94:1997;8485-8490.
47. Miesfeld R, Okret S, Wikström ACet al. Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells. Nature. 312:1984;779-781.
48. Newmark JR, Hardy DO, Tonb DCet al. Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci U S A. 89:1992;6319-6323.
49. Perutz MF, Johnson T, Suzuki M, Finch JT Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci U S A. 91:1994;5355-5358.
50. Quigley CA, DeBellis A, Marschke KB, El-Awady MK, Wilson EM, French FS Androgen receptor defects: historical, clinical and molecular perspectives. Endocr Rev. 16:1995;271-321.
51. Russell DW, Wilson JD Steroid 5α-reductase: two genes/two enzymes. Annu Rev Biochem. 63:1994;25-61.
52. Shibata H, Spencer TE, Onate SAet al. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res. 52:1997;141-164.
53. Smith DF, Toft DO Steroid receptors and their associated proteins. Mol Endocrinol. 7:1993;4-11.
54. Stanford JL, Just JJ, Gibbs Met al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res. 57:1997;1194-1198.
55. Taplin ME, Bubley GJ, Shuster TDet al. Mutation of the androgen receptor gene in metastatic androgen-dependent prostate cancer. New Engl J Med. 332:1995;1393-1398.
56. Trifiro MA, Kazemi-Esfarjani P, Pinsky L X-Linked muscular atrophy and the androgen receptor. Trends Endocrinol Metab. 5:1994;416-421.
57. Umekita Y, Hiipakka RA, Kokontis JM, Liao S Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by a 5α-reductase inhibitor. Proc Natl Acad Sci U S A. 93:1996;11802-11807.
58. Veldscholte J, Ris-Stalpers C, Kuiper GGJMet al. A mutation in ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun. 173:1990;534-540.
59. Williams-Ashmann HG New facets of the biochemistry of steroid hormone action. Cancer Res. 25:1965;1096-1120.
60. Wilson JD Syndromes of androgen resistance. Biol Reprod. 46:1992;168-173.
61. Wurtz JM, Bourguet W, Renaud JPet al. A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol. 3:1996;87-94.
62. Yeh S, Miyamoto H, Shima H, Chang C From estrogen to androgen receptor: a new pathway for sex hormones in prostate. Proc Natl Acad Sci U S A. 95:1998;5527-5532.
63. Zhou Z, Kemppainen JA, Wilson EM Identification of three proline-directed phosphorylation sites in the human androgen receptor. Mol Endocrinol. 9:1995;605-615.